EC Number | General Stability | Organism |
---|---|---|
1.1.1.196 | unstable | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.196 | 11,14-Eicosadienoic acid | - |
Sus scrofa | |
1.1.1.196 | 3,3',5-Triiodothyroacetic acid | - |
Sus scrofa | |
1.1.1.196 | arachidonic acid | - |
Sus scrofa | |
1.1.1.196 | Flufenamic acid | - |
Sus scrofa | |
1.1.1.196 | indomethacin | - |
Sus scrofa | |
1.1.1.196 | L-thyroxine | - |
Sus scrofa | |
1.1.1.196 | linoleic acid | - |
Sus scrofa | |
1.1.1.196 | N-ethylmaleimide | - |
Sus scrofa | |
1.1.1.196 | p-chloromercuribenzoate | - |
Sus scrofa | |
1.1.1.196 | palmitic acid | - |
Sus scrofa |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.196 | 0.0004 | - |
NADP+ | - |
Sus scrofa | |
1.1.1.196 | 0.052 | - |
Prostaglandin D2 | - |
Sus scrofa | |
1.1.1.196 | 0.278 | - |
prostaglandin D1 | - |
Sus scrofa | |
1.1.1.196 | 0.35 | - |
prostaglandin E2 | - |
Sus scrofa | |
1.1.1.196 | 0.4 | - |
prostaglandin F2alpha | - |
Sus scrofa | |
1.1.1.196 | 0.54 | - |
prostaglandin I2 | - |
Sus scrofa |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
1.1.1.196 | 28000 | - |
gel electrophoresis | Sus scrofa |
1.1.1.196 | 29000 | - |
1 * 29000 | Sus scrofa |
1.1.1.196 | 30000 | - |
sedimentation equilibrium | Sus scrofa |
1.1.1.196 | 32000 | - |
gel filtration | Sus scrofa |
1.1.1.196 | 52000 | - |
gel filtration | Sus scrofa |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.196 | prostaglandin D2 + NADP+ | Homo sapiens | specific inactivation of prostaglandin D2 in the brain, in the central nervous system and also in blood platelets | 15-ketoprostaglandin D2 + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin D2 + NADP+ | Sus scrofa | specific inactivation of prostaglandin D2 in the brain, in the central nervous system and also in blood platelets | 15-ketoprostaglandin D2 + NADPH + H+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.196 | Homo sapiens | - |
human | - |
1.1.1.196 | Sus scrofa | - |
swine | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.1.1.196 | - |
Sus scrofa |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.1.1.196 | blood | platelet | Homo sapiens | - |
1.1.1.196 | brain | - |
Homo sapiens | - |
1.1.1.196 | brain | - |
Sus scrofa | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.1.1.196 | 0.0212 | - |
- |
Sus scrofa |
EC Number | Storage Stability | Organism |
---|---|---|
1.1.1.196 | 4°C, at pH 7 for 6 h, 54% loss of enzyme activity | Sus scrofa |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.196 | prostaglandin D1 + NADP+ | - |
Sus scrofa | 15-ketoprostaglandin D1 + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin D2 + NADP+ | - |
Homo sapiens | 15-ketoprostaglandin D2 + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin D2 + NADP+ | - |
Sus scrofa | 15-ketoprostaglandin D2 + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin D2 + NADP+ | specific inactivation of prostaglandin D2 in the brain, in the central nervous system and also in blood platelets | Homo sapiens | 15-ketoprostaglandin D2 + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin D2 + NADP+ | specific inactivation of prostaglandin D2 in the brain, in the central nervous system and also in blood platelets | Sus scrofa | 15-ketoprostaglandin D2 + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin E2 + NADP+ | - |
Sus scrofa | 15-ketoprostaglandin E2 + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin F2alpha + NADP+ | - |
Sus scrofa | 15-ketoprostaglandin F2alpha + NADPH + H+ | - |
? | |
1.1.1.196 | prostaglandin I2 + NADP+ | - |
Sus scrofa | 15-ketoprostaglandin I2 + NADPH + H+ | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
1.1.1.196 | monomer | 1 * 28000, SDS-PAGE | Sus scrofa |
1.1.1.196 | monomer | 1 * 29000 | Sus scrofa |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.1.1.196 | 9.5 | - |
optimal for reaction with prostaglandins D1, D2, E2 and I2 | Sus scrofa |
1.1.1.196 | 9.5 | 10 | with prostaglandin F2alpha as substrate | Sus scrofa |
EC Number | pH Stability | pH Stability Maximum | Comment | Organism |
---|---|---|---|---|
1.1.1.196 | 7 | - |
most stable at pH 7 with 54% loss of activity, loses 100% activity at pH 5, 70% at pH 6, 76% at pH 8 and 100% at pH 9 | Sus scrofa |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.196 | NADP+ | strict specificity for | Sus scrofa |